"pancreatic tumor progression" trang 15 - tải miễn phí từ tailieunhanh
KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer

KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer
16    50    1
First reported case of a collision tumor composed of pancreatic adenocarcinoma and retroperitoneal liposarcoma: A case report

First reported case of a collision tumor composed of pancreatic adenocarcinoma and retroperitoneal liposarcoma: A case report
6    41    1
Early venous thromboembolism at the beginning of palliative chemotherapy is a poor prognostic factor in patients with metastatic pancreatic cancer: A retrospective study

Early venous thromboembolism at the beginning of palliative chemotherapy is a poor prognostic factor in patients with metastatic pancreatic cancer: A retrospective study
10    46    1
Semaphorin-5A maintains epithelial phenotype of malignant pancreatic cancer cells

Semaphorin-5A maintains epithelial phenotype of malignant pancreatic cancer cells
15    51    1
Genome-wide CRISPR screen reveals PSMA6 to be an essential gene in pancreatic cancer cells

Genome-wide CRISPR screen reveals PSMA6 to be an essential gene in pancreatic cancer cells
12    36    1
Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: A multicenter case-control study of 240 patients

Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: A multicenter case-control study of 240 patients
12    43    1
Meta-analysis on resected pancreatic cancer: A comparison between adjuvant treatments and gemcitabine alone

Meta-analysis on resected pancreatic cancer: A comparison between adjuvant treatments and gemcitabine alone
8    67    1
A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis

A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis
11    60    1
Solitary pancreatic metastasis of extremity myxoid liposarcoma: A case report and literature review

Solitary pancreatic metastasis of extremity myxoid liposarcoma: A case report and literature review
7    24    1
Engaging the older cancer patient; Patient Activation through Counseling, Exercise and Mobilization – Pancreatic, Biliary tract and Lung cancer (PACE-Mobil-PBL) - study protocol of a randomized controlled trial

Engaging the older cancer patient; Patient Activation through Counseling, Exercise and Mobilization – Pancreatic, Biliary tract and Lung cancer (PACE-Mobil-PBL) - study protocol of a randomized controlled trial
11    230    1
Protocol of the PANCALYZE trial: A multicenter, prospective study investigating the tumor biomarkers CXCR4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease

Protocol of the PANCALYZE trial: A multicenter, prospective study investigating the tumor biomarkers CXCR4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease
9    53    1
Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo

Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo
13    37    1
Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mobility assay device

Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mobility assay device
11    77    1
Inhibition of Six1 affects tumour invasion and the expression of cancer stem cell markers in pancreatic cancer

Inhibition of Six1 affects tumour invasion and the expression of cancer stem cell markers in pancreatic cancer
10    30    1
Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma

Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma
11    48    1
A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients

A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients
9    33    1
Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo

Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo
11    56    1
Efficacy and safety profile of nab-paclitaxel plus gemcitabine in patients with metastatic pancreatic cancer treated to disease progression: A subanalysis from a phase 3 trial (MPACT)

Efficacy and safety profile of nab-paclitaxel plus gemcitabine in patients with metastatic pancreatic cancer treated to disease progression: A subanalysis from a phase 3 trial (MPACT)
10    64    1
Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and review

Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and review
8    37    1
Disseminated carcinomatosis of the bone marrow from pancreatic cancer: A case report

Disseminated carcinomatosis of the bone marrow from pancreatic cancer: A case report
6    51    1